Top 40 Entrada Therapeutics investors
The most complete profiles first. Showing 40 of 42.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Geeta VemuriVerified
Venture Capital, Founder, Private Equity Firm · United States
Series AHealth CareGeneticsWomen FoundedLife SciencePortfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 12 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Pete CasellaVerified
Venture Capital, Investor · United States
Series AHealth CareGeneticsAccountingCybersecurityPortfolio: Acorns, Praxis Precision Medicines, Spherical Defense, MX Technologies and 59 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Eric ThompsonVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
John AvirettVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
John WuestlingVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Stephen WestVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Preston Noon
Venture Capital, Private Equity Firm, Micro VC · United States
Series AHealth CareGeneticsWomen FoundedLife SciencePortfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 9 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
C. Ashton Newhall
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Deric Emry
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Lindsay Redfield
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Matthew Granade
Venture Capital · United States
Health CareGeneticsAccountingCybersecurityPortfolio: Acorns, Praxis Precision Medicines, Spherical Defense, MX Technologies and 58 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Todd Ruppert
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Beau MorrisonVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: Entrada Therapeutics, Photys Therapeutics
Verified email available
See all 42 Entrada Therapeutics investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Entrada Therapeutics investors are on Angel Roster?
Angel Roster lists 42 Entrada Therapeutics investors. 19 of them (45%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (42), Private Equity Firms (21) and Secondary Purchaser Investors (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Entrada Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (13) and Series A (3).
Where are Entrada Therapeutics investors based?
Most are based in the United States (42).
Which companies have Entrada Therapeutics investors backed?
The most-backed portfolio companies among them are Aprea (18), Cabaletta Bio (18), Audentes Therapeutics (18), Escient Pharmaceuticals (18) and Neurogastrx (16).
How do I contact Entrada Therapeutics investors?
Create a free Angel Roster account to search and filter all 42, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.